Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians (Observ-MTEV)

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Pulmonary Embolism

Venous Thromboembolism

Deep Vein Thrombosis

Anticoagulant

Survey

Study type

Observational

Funder types

Other

Identifiers

NCT04272723

PI2020_843_0014

Details and patient eligibility

About

In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France

Enrollment

383 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

vascular medicine physicians who are active members of the SFMV (French Society of Vascular Medicine)
vascular medicine physicians registered as willing to do medical research

Exclusion criteria